Although ETS-1 may play a role in chemotherapy resistance in lung, ovarian, and colorectal cancers, its precise role in cisplatin-resistant HNSCC has not been well documented [5]. This evidence concerns the gene ETS1 and head and neck squamous cell carcinoma.